Policy & Regulation
South Rampart Pharma names new chief financial officer
17 August 2022 -

South Rampart Pharma, a US-based clinical-stage life science company that said it is advancing innovative medications for the treatment of pain and fever, announced on Tuesday that it has named Josh Blacher as its new chief financial officer.

In the new role, Blacher will be responsible for the firm's finance and accounting department, and for introducing a robust corporate development effort.

Blacher has more than twenty years of leadership experience in senior positions in the healthcare and capital markets sectors. He helped build and handle Teva Innovative Ventures. He has held the position of CFO/CBO at three publicly traded biotechnology companies, the most recent of which was Inmed Pharmaceuticals. He has served in senior positions in portfolio management at Deutsche Asset Management and equity research at Morgan Stanley and in mergers & acquisitions at Lehman Brothers.